Sciencast Management LP Glaukos Corp Transaction History

Sciencast Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$34.86 - $63.77 $201,316 - $368,271	5,775 New	5,775 $307,000
Q2 2021 Jul 28, 2021	SELL	$73.06 - $97.7 $800,883 - $1.07 Million	-10,962 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$70.43 - $97.42 $772,053 - $1.07 Million	10,962 New	10,962 $934,000
Q4 2020 Feb 04, 2021	SELL	$48.9 - $75.26 $259,170 - $398,878	-5,300 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$37.23 - $50.97 $197,318 - $270,141	5,300 New	5,300 $285,000
Q2 2020 Jul 29, 2020	SELL	$28.78 - $46.83 $216,281 - $351,927	-7,515 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$25.53 - $70.14 $191,857 - $527,102	7,515 New	7,515 $220,000
Q4 2019 Jan 16, 2020	SELL	$54.18 - $65.64 $493,038 - $597,324	-9,100 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$58.58 - $83.91 $533,078 - $763,581	9,100 New	9,100 $562,000

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

Stay updated on Sciencast Management LP with notifications on news.